Insider Trading activities at Anika Therapeutics, Inc. (ANIK)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Anika Therapeutics, Inc. (ANIK) since 2015 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Anika Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 898437.

Total stock buying since 2015: $691,827.
Total stock sales since 2015: $10,609,875.
Total stock option exercises since 2015: $530,160.


18 insiders reported insider trading activities at Anika Therapeutics, Inc. (ANIK):
Insider trading activities of Blanchard Cheryl R
Insider trading activities of Sherwood Charles H
Insider trading activities of Colleran David
Insider trading activities of Levitz Michael L
Insider trading activities of Bower Joseph I
Insider trading activities of Wheeler Steve E
Insider trading activities of Thompson Jeffery S
Insider trading activities of Nunes Anne
Insider trading activities of Larsen Glenn R.
Insider trading activities of Land Raymond J
Insider trading activities of Loerop James
Insider trading activities of Finnerty Thomas
Insider trading activities of Hague Richard
Insider trading activities of Moran John C
Insider trading activities of Darling Joseph G
Insider trading activities of Griffin Stephen D.
Insider trading activities of Henneman John B Iii
Insider trading activities of Cheung Sylvia

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Anika Therapeutics, Inc. (ANIK).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 0 $0 117,104 $0
2024 0 $0 0 $0 108,837 $0
2023 0 $0 0 $0 100,077 $0
2022 17,100 $427,081 0 $0 61,857 $0
2021 5,627 $231,546 2,000 $85,200 33,934 $0
2020 0 $0 7,390 $285,671 4,231 $0
2019 1,000 $33,200 38,192 $2,127,119 35,000 $222,600
2017 0 $0 142,524 $7,587,868 10,000 $89,900
2016 0 $0 540 $23,411 6,170 $69,710
2015 0 $0 13,329 $500,606 12,810 $147,950

Table 2. Monthly summary of insider trading at Anika Therapeutics, Inc. (ANIK).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 0 $0 0 $0 12,840 $0
2025-03 0 $0 0 $0 104,264 $0
2024-10 0 $0 0 $0 2,491 $0
2024-03 0 $0 0 $0 106,346 $0
2023-10 0 $0 0 $0 2,491 $0
2023-08 0 $0 0 $0 3,859 $0
2023-04 0 $0 0 $0 24,575 $0
2023-03 0 $0 0 $0 69,152 $0
2022-08 0 $0 0 $0 3,859 $0
2022-05 1,500 $32,055 0 $0 0 $0
2022-04 0 $0 0 $0 24,576 $0
2022-03 15,600 $395,026 0 $0 27,588 $0
2022-02 0 $0 0 $0 5,834 $0
2021-08 3,627 $145,826 0 $0 3,859 $0
2021-07 0 $0 0 $0 3,000 $0
2021-05 2,000 $85,720 2,000 $85,200 0 $0
2021-04 0 $0 0 $0 24,575 $0
2021-03 0 $0 0 $0 2,500 $0
2020-11 0 $0 3,446 $126,709 0 $0
2020-07 0 $0 1,244 $43,726 0 $0
2020-04 0 $0 0 $0 4,231 $0
2020-02 0 $0 2,700 $115,236 0 $0
2019-11 0 $0 20,000 $1,194,200 35,000 $222,600
2019-08 0 $0 11,192 $634,359 0 $0

Table 3. Detailed insider trading at Anika Therapeutics, Inc. (ANIK)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-03 Griffin Stephen D. (EVP, CFO & COO) Option Ex 12,840 .00 0
2025-03-17 Nunes Anne (SVP, Chief Operations Officer) Option Ex 3,637 .00 0
2025-03-17 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 6,448 .00 0
2025-03-17 Blanchard Cheryl R (President, CEO, Director) Option Ex 25,132 .00 0
2025-03-11 Nunes Anne (SVP, Chief Operations Officer) Option Ex 2,561 .00 0
2025-03-11 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 7,663 .00 0
2025-03-11 Blanchard Cheryl R (President, CEO, Director) Option Ex 30,060 .00 0
2025-03-10 Nunes Anne (SVP, Chief Operations Officer) Option Ex 3,296 .00 0
2025-03-10 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 5,465 .00 0
2025-03-10 Blanchard Cheryl R (President, CEO, Director) Option Ex 20,002 .00 0
2024-10-01 Nunes Anne (SVP, Chief Operations Officer) Option Ex 2,491 .00 0
2024-03-11 Nunes Anne (SVP, Chief Operations Officer) Option Ex 5,856 .00 0
2024-03-11 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 16,809 .00 0
2024-03-11 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 19,201 .00 0
2024-03-11 Blanchard Cheryl R (President, CEO, Director) Option Ex 64,480 .00 0
2023-10-01 Nunes Anne (SVP, Chief Operations Officer) Option Ex 2,491 .00 0
2023-08-10 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 3,859 .00 0
2023-04-26 Blanchard Cheryl R (President, CEO, Director) Option Ex 24,575 .00 0
2023-03-10 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 7,663 .00 0
2023-03-10 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 8,888 .00 0
2023-03-10 Blanchard Cheryl R (President, CEO, Director) Option Ex 30,060 .00 0
2023-03-09 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 3,683 .00 0
2023-03-09 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 4,439 .00 0
2023-03-09 Blanchard Cheryl R (President, CEO, Director) Option Ex 14,419 .00 0
2022-08-10 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 3,859 .00 0
2022-05-11 Colleran David (EVP, General Counsel, Corp Sec) Buy 1,500 21.37 32,055
2022-04-26 Blanchard Cheryl R (President, CEO, Director) Option Ex 24,576 .00 0
2022-03-14 Colleran David (EVP, General Counsel, Corp Sec) Buy 1,500 26.65 39,978
2022-03-11 Thompson Jeffery S Buy 2,000 24.66 49,318
2022-03-11 Levitz Michael L (EVP, CFO, Treasurer) Buy 4,000 24.62 98,476
2022-03-11 Blanchard Cheryl R (President, CEO, Director) Buy 8,100 25.59 207,254
2022-03-09 Finnerty Thomas (EVP, Human Resources) Option Ex 2,548 .00 0
2022-03-09 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 3,682 .00 0
2022-03-09 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 4,438 .00 0
2022-03-09 Blanchard Cheryl R (President, CEO, Director) Option Ex 14,420 .00 0
2022-03-04 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 2,500 .00 0
2022-02-26 Finnerty Thomas (EVP, Human Resources) Option Ex 3,000 .00 0
2022-02-25 Finnerty Thomas (EVP, Human Resources) Option Ex 2,834 .00 0
2021-08-12 Levitz Michael L (EVP, CFO, Treasurer) Buy 777 40.20 31,239
2021-08-11 Levitz Michael L (EVP, CFO, Treasurer) Buy 2,850 40.21 114,587
2021-08-10 Levitz Michael L (EVP, CFO, Treasurer) Option Ex 3,859 .00 0
2021-07-08 Loerop James (EVP Business Development) Option Ex 3,000 .00 0
2021-05-18 Henneman John B Iii Buy 2,000 42.86 85,720
2021-05-12 Land Raymond J Sale 2,000 42.60 85,200
2021-04-26 Blanchard Cheryl R (President, CEO, Director) Option Ex 24,575 .00 0
2021-03-04 Colleran David (EVP, General Counsel, Corp Sec) Option Ex 2,500 .00 0
2020-11-10 Land Raymond J Sale 3,446 36.77 126,709
2020-07-09 Loerop James (EVP Business Development) Sale 1,244 35.15 43,726
2020-04-26 Blanchard Cheryl R (President, CEO, Director) Option Ex 4,231 .00 0
2020-02-26 Land Raymond J Sale 2,700 42.68 115,236
2019-11-08 Cheung Sylvia (Chief Financial Officer) Sale 20,000 59.71 1,194,200
2019-11-06 Cheung Sylvia (Chief Financial Officer) Option Ex 35,000 6.36 222,600
2019-08-28 Larsen Glenn R. Sale 4,355 57.21 249,149
2019-08-20 Bower Joseph L. Sale 1,994 55.57 110,806
2019-08-08 Thompson Jeffery S Sale 4,843 56.66 274,404
2019-07-29 Land Raymond J Sale 3,000 55.44 166,320
2019-02-28 Darling Joseph G (President and CEO; Director) Buy 1,000 33.20 33,200
2019-02-26 Land Raymond J Sale 4,000 33.06 132,240
2017-11-30 Hague Richard (Chief Commercial Officer) Sale 5,250 54.48 286,020
2017-10-24 Sherwood Charles H (CEO and Director) Sale 3,278 60.04 196,811
2017-10-23 Sherwood Charles H (CEO and Director) Sale 22,228 60.06 1,335,013
2017-10-20 Sherwood Charles H (CEO and Director) Sale 5,991 60.04 359,699
2017-10-16 Sherwood Charles H (CEO and Director) Sale 3,293 60.04 197,711
2017-10-13 Sherwood Charles H (CEO and Director) Sale 5,216 60.11 313,533
2017-10-12 Sherwood Charles H (CEO and Director) Sale 1,908 60.00 114,480
2017-07-27 Sherwood Charles H (CEO and Director) Sale 63,799 50.79 3,240,351
2017-07-05 Sherwood Charles H (President, CEO, Director) Sale 8,236 50.06 412,294
2017-07-03 Sherwood Charles H (President, CEO, Director) Sale 5,965 50.00 298,250
2017-05-22 Thompson Jeffery S Sale 9,628 47.37 456,078
2017-05-19 Thompson Jeffery S Sale 1,097 47.58 52,195
2017-02-22 Cheung Sylvia (Chief Financial Officer) Sale 4,000 49.03 196,108
2017-02-22 Cheung Sylvia (Chief Financial Officer) Option Ex 10,000 8.99 89,900
2017-02-22 Land Raymond J Sale 2,635 49.08 129,325
2016-11-09 Bower Joseph I Sale 540 43.35 23,411
2016-11-07 Bower Joseph I Option Ex 1,540 12.36 19,034
2016-11-02 Wheeler Steve E Option Ex 1,090 12.36 13,472
2016-01-26 Wheeler Steve E Option Ex 1,770 10.51 18,602
2016-01-26 Bower Joseph I Option Ex 1,770 10.51 18,602
2015-08-07 Moran John C Sale 2,000 36.18 72,360
2015-07-31 Cheung Sylvia (Chief Financial Officer) Option Ex 5,000 12.61 63,050
2015-07-31 Land Raymond J Sale 1,018 37.76 38,439
2015-07-30 Land Raymond J Sale 690 37.39 25,799
2015-07-30 Land Raymond J Option Ex 1,540 12.36 19,034
2015-05-27 Moran John C Sale 2,500 33.00 82,500
2015-02-27 Land Raymond J Sale 4,621 39.49 182,483
2015-02-26 Moran John C Sale 2,500 39.61 99,025
2015-02-26 Land Raymond J Option Ex 6,270 10.51 65,866

Insider trading activities including stock purchases, stock sales, and option exercises of ANIK listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Anika Therapeutics, Inc. (symbol ANIK, CIK number 898437) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.